Paulash Mohsen
Chief Business Officer, Proteostasis Therapeutics (United States).
Companies
- Proteostasis Therapeutics (United States)Chief Business Officer Dec 28, 2020 to Feb 7, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Proteostasis Therapeutics (United States)59,135 shares2Feb 3, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 3, 2022Sold 1,958 shares at $1.83 of Proteostasis Therapeutics (United States)2
- Dec 1, 2021Granted 20,000 shares of Proteostasis Therapeutics (United States)3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Dec 3, 2021